TY  - GEN
AU  - Suzuki,R
AU  - Hideshima,T
AU  - Mimura,N
AU  - Minami,J
AU  - Ohguchi,H
AU  - Kikuchi,S
AU  - Yoshida,Y
AU  - Gorgun,G
AU  - Cirstea,D
AU  - Cottini,F
AU  - Jakubikova,J
AU  - Tai,Y-T
AU  - Chauhan,D
AU  - Richardson,P G
AU  - Munshi,N C
AU  - Utsugi,T
AU  - Anderson,K C
TI  - Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma
SN  - 1476-5551
PY  - 2015///0406
KW  - Animals
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Apoptosis
KW  - Benzamides
KW  - Boronic Acids
KW  - Bortezomib
KW  - Cell Line
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Cell Survival
KW  - Drug Screening Assays, Antitumor
KW  - HSP90 Heat-Shock Proteins
KW  - antagonists & inhibitors
KW  - Humans
KW  - Mice
KW  - Mice, SCID
KW  - Monomeric GTP-Binding Proteins
KW  - metabolism
KW  - Multiple Myeloma
KW  - drug therapy
KW  - Mutation
KW  - Neoplasm Transplantation
KW  - Pyrazines
KW  - Pyrazoles
KW  - Retinal Pigment Epithelium
KW  - cytology
N1  - Publication Type: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/leu.2014.300
ER  -